Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fan, X.
Right arrow Articles by Rouleau, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, X.
Right arrow Articles by Rouleau, G. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 21 2341-2351
© 2001 Oxford University Press

Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death

Xueping Fan, Patrick Dion, Janet Laganiere, Bernard Brais1 and Guy A. Rouleau+

Center for Research in Neuroscience, McGill University, and the McGill University Health Center, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada and 1Centre de recherche du CHUM, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke East, Montreal, Quebec H2L 4M1, Canada

Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disorder characterized by progressive eyelid drooping, swallowing difficulties and proximal limb weakness. The autosomal dominant form of this disease is caused by short expansions of a (GCG)6 repeat to (GCG)8–13 in the PABPN1 gene, which results in the expansion of a polyalanine stretch from 10 to 12–17 alanines in the N-terminus of the protein. Mutated PABPN1 (mPABPN1) is able to induce nuclear protein aggregation and form filamentous nuclear inclusions, which are the pathological hallmarks of OPMD. PABPN1, when bound to poly(A) RNA, forms both linear filaments and discrete-sized, compact oligomeric particles in vitro. In the absence of poly(A) RNA, PABPN1 can form oligomers. Here we report that: (i) oligomerization of PABPN1 is mediated by two potential oligomerization domains (ODs); (ii) inactivating oligomerization of mPABPN1 by deletions of 6–8 amino acids in either of the ODs prevents nuclear protein aggregation; (iii) expression of mPABPN1 in COS-7 cells is associated with cell death; and (iv) preventing nuclear protein aggregation by inactivating oligomerization of mPABPN1 significantly reduces cell death. These findings suggest that oligomerization of PABPN1 plays a crucial role in the formation of OPMD nuclear protein aggregation, while the expanded polyalanine stretch is necessary but not sufficient to induce OPMD protein aggregation, and that the nuclear protein aggregation might be toxic and cause cell death. These observations also imply that inactivation of oligomerization of mPABPN1 might be a useful therapeutic strategy for OPMD.

+ To whom correspondence should be addressed at: Room L7-224, Montreal General Hospital, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada. Tel: +1 514 934 8094; Fax: +1 514 934 8265; Email: mi32@musica.mcgill.ca


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
K. Fronz, S. Otto, K. Kolbel, U. Kuhn, H. Friedrich, A. Schierhorn, A. G. Beck-Sickinger, A. Ostareck-Lederer, and E. Wahle
Promiscuous Modification of the Nuclear Poly(A)-binding Protein by Multiple Protein-arginine Methyltransferases Does Not Affect the Aggregation Behavior
J. Biol. Chem., July 18, 2008; 283(29): 20408 - 20420.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. E. Davies, S. Sarkar, and D. C. Rubinsztein
Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation
Hum. Mol. Genet., April 15, 2008; 17(8): 1097 - 1108.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. Guerrini, F. Moro, M. Kato, A. J. Barkovich, T. Shiihara, M. A. McShane, J. Hurst, M. Loi, J. Tohyama, V. Norci, et al.
Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus
Neurology, July 31, 2007; 69(5): 427 - 433.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Perreault, C. Lemieux, and F. Bachand
Regulation of the Nuclear Poly(A)-binding Protein by Arginine Methylation in Fission Yeast
J. Biol. Chem., March 9, 2007; 282(10): 7552 - 7562.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
N. Hosoda, F. Lejeune, and L. E. Maquat
Evidence that Poly(A) Binding Protein C1 Binds Nuclear Pre-mRNA Poly(A) Tails
Mol. Cell. Biol., April 15, 2006; 26(8): 3085 - 3097.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
P. Verheesen, A. de Kluijver, S. van Koningsbruggen, M. de Brij, H. J. de Haard, G.-J. B. van Ommen, S. M. van der Maarel, and C. T. Verrips
Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody
Hum. Mol. Genet., January 1, 2006; 15(1): 105 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. Moumne, M. Fellous, and R. A. Veitia
Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation
Hum. Mol. Genet., December 1, 2005; 14(23): 3557 - 3564.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Q. Wang, D. D. Mosser, and J. Bag
Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells
Hum. Mol. Genet., December 1, 2005; 14(23): 3673 - 3684.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Nakano, A. Shinde, H. Ito, H. Ito, and H. Kusaka
Messenger RNA degradation may be inhibited in sporadic inclusion body myositis
Neurology, August 9, 2005; 65(3): 420 - 425.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
J. P. TAVANEZ, P. CALADO, J. BRAGA, M. LAFARGA, and M. CARMO-FONSECA
In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1
RNA, May 1, 2005; 11(5): 752 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
N. G. Faux, S. P. Bottomley, A. M. Lesk, J. A. Irving, J. R. Morrison, M. G. de la Banda, and J. C. Whisstock
Functional insights from the distribution and role of homopeptide repeat-containing proteins
Genome Res., April 1, 2005; 15(4): 537 - 551.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. Brown, M. Paraso, R. Arkell, and S. Brown
In vitro analysis of partial loss-of-function ZIC2 mutations in holoprosencephaly: alanine tract expansion modulates DNA binding and transactivation
Hum. Mol. Genet., February 1, 2005; 14(3): 411 - 420.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M.-J. Caron, F. Girard, D. C. Girard, D. Boudreault, B. Brais, E. Nassif, P. Chouinard, M. Ruel, and A. Duranceau
Cisatracurium Pharmacodynamics in Patients with Oculopharyngeal Muscular Dystrophy
Anesth. Analg., February 1, 2005; 100(2): 393 - 397.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
I. M. Nasrallah, J. C. Minarcik, and J. A. Golden
A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death
J. Cell Biol., November 8, 2004; 167(3): 411 - 416.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. T. Berciano, N. T. Villagra, J. L. Ojeda, J. Navascues, A. Gomes, M. Lafarga, and M. Carmo-Fonseca
Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus
Hum. Mol. Genet., April 15, 2004; 13(8): 829 - 838.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. Hino, K. Araki, E. Uyama, M. Takeya, M. Araki, K. Yoshinobu, K. Miike, Y. Kawazoe, Y. Maeda, M. Uchino, et al.
Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy
Hum. Mol. Genet., January 15, 2004; 13(2): 181 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Abu-Baker, C. Messaed, J. Laganiere, C. Gaspar, B. Brais, and G. A. Rouleau
Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy
Hum. Mol. Genet., October 16, 2003; 12(20): 2609 - 2623.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. Kuhn, A. Nemeth, S. Meyer, and E. Wahle
The RNA Binding Domains of the Nuclear poly(A)-binding Protein
J. Biol. Chem., May 2, 2003; 278(19): 16916 - 16925.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
B. Ravikumar, R. Duden, and D. C. Rubinsztein
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
Hum. Mol. Genet., May 1, 2002; 11(9): 1107 - 1117.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. P. Bao, L. J. Cook, D. O'Donovan, E. Uyama, and D. C. Rubinsztein
Mammalian, Yeast, Bacterial, and Chemical Chaperones Reduce Aggregate Formation and Death in a Cell Model of Oculopharyngeal Muscular Dystrophy
J. Biol. Chem., March 29, 2002; 277(14): 12263 - 12269.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.